Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$THLD Presents at Stifel Nicolaus Healthcare Conference today @ 10:55 EST. Stifel Nicolaus currently projects $THLD to hit $15 PPS.
$THLD is presenting at Stifel Nicolaus Healthcare Conference today. Stifel Nicolaus analysts currently project THLD to hit $15 per share. You can listen to the presentation live here: http://www.veracast.com/webcasts/stifel/healthcare2013/75106443349.cfm . The presentation begins at 10:55 EST. Goodluck, guys!
Does anyone have any idea as to why Jaeger is consistently dumping so many shares of $THLD? I have faith in this company and what they're doing, but their director selling off so much is a little worrisome to me. I know that some of it a bit back were options being exercised, but it doesn't look to be the case the last bit. Or am I wrong?
Today at 3:30 EST, THLD presents @ JMP Securities Healthcare Conference. Listen live here: http://investor.thresholdpharm.com/events.cfm
The only thing I have to say is I bought another $5000 worth at $5.07, adding to my position! Hopefully it's KILLER interim data.
I'm right there with you. What's the deal!?
$PRTS gets several upgraded ratings! Price Target = $4.20
"Thomson Reuters/Verus upgraded shares of U.S. Auto Parts Netw (NASDAQ: PRTS) from a sell rating to a hold rating in a research report sent to investors on Tuesday morning, AnalystRatings.Net reports.
Separately, analysts at Roth Capital upgraded shares of U.S. Auto Parts Netw from a neutral rating to a buy rating in a research note to investors on Wednesday, May 8th.
One analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the stock. U.S. Auto Parts Netw currently has an average rating of Hold and a consensus price target of $4.20."
Source: http://www.dailypolitical.com/finance/stock-market/thomson-reutersverus-upgrades-u-s-auto-parts-netw-to-hold-prts.htm
Anyone have the details of the conference at the 14th Annual B. Riley & Co. Investor Conference in Santa Monica, California from May 20th? Can't find anything anywhere.
Anyone got any outlooks for $PRTS? Just took out a $5000 stake in the company.
Scott Matusow breaks down $THLD's move today:
Already been on there and read it all. Some thoroughbred weirdos running around there. Sad dudes. Anyways, I'd really love to know what's going on to merit a 7% crash like this. Maybe just a pullback from profit taking?
Anyone have a clue as to what in the hell is going on today?
Double? Son, we have triple digits on lockdown! lol
Today's THLD presentation is up at: http://wsw.com/webcast/needham58/thld/
Tomorrow (4-30-2013) at 1:40 PM EST, THLD will be presenting at the Needham Healthcare Conference. I've heard rumors about some good data being presented and released, keep your fingers crossed, guys! Don't miss it tomorrow at 1:40 pm EST, you can check it out and register for the event on Threshold's investor page here: http://investor.thresholdpharm.com/events.cfm
$THLD to present at Needham Healthcare Conference on Monday, 4-30-2013. http://www.4-traders.com/THRESHOLD-PHARMACEUTICALS-4706838/news/Threshold-Pharmaceuticals-Inc-Threshold-Pharmaceuticals-Announces-Presentation-and-Webcast-at-th-16775097/
IT IS TOO QUIET.
Anybody have any idea what's up with this? Seems smear-y.
"NEW YORK, April 3, 2013 /PRNewswire/ – Levi & Korsinsky, LLP is investigating Threshold Pharmaceuticals Inc. (NasdaqCM: THLD), and its Board of Directors, in connection with possible claims of breaches of fiduciary duty.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes."
Maybe it's due to the competition, Celgene's Abraxane, reporting yesterday an average overall shorter extension of life than what Threshold's TH-302 is reporting? Might be speaking early, but it's just a hypothesis, but then again, what isn't a hypothesis in the trading world? Link: http://www.4-traders.com/CELGENE-CORPORATION-8736/news/Celgene-Says-Pancreatic-Cancer-Drug-Extends-Life-by-Nearly-2-Months-15959692/
Up, up, and away! Let's see those 12 and 15 target prices become a reality!
$THLD up 10.12% at the moment! Does anyone know what is causing this? Any news I'm overlooking?
Good lord what a relentless smear campaign. It reminds me of the election. Chimera and seeking alpha keep regurgitating the same old rehashed trash with no new data or evidence. Clear bias and slander.
Can you elaborate on this? Thank you.
Seeking Alpha/Chimera beating down $THLD, commentators firing back with some valid points. SA and Chimera makes this feel like a smear campaign fit for politicians. $THLD has a good future, be sure to read the comments on this rubbish article since that is where the only valuable information is located.
http://seekingalpha.com/article/944831-what-s-left-for-threshold-not-much
Very same here. Target prices are still very high. The SPA that was recently agreed upon with the FDA should help skew the trial results into a favorable realm and give them some REAL ground to walk on. Once we begin to hear of the fruit from that, I feel as though $THLD will flourish.
A little insight on THLD's SPA agreement with the FDA http://www.fool.com/investing/general/2012/10/17/2-biotechs-get-the-fdas-approval.aspx
$THLD announces Presentation & Webcast http://www.equities.com/news/headline-story?dt=2012-10-04&val=557632&cat=hcare
Three Best Biotechs for this week: http://seekingalpha.com/article/901731-3-best-biotech-stocks-for-this-week-part-iv
Maxim Group: $THLD is a BUY target @ $10
http://www.benzinga.com/analyst-ratings/analyst-color/12/10/2955618/maxim-group-reiterates-buy-rating-10-pt-on-threshold-pha#
Stifel Nicolaus Sets $THLD Target at $15.00 (THLD) http://www.dailypolitical.com/finance/stock-market/stifel-nicolaus-sets-threshold-pharma-price-target-at-15-00-thld.htm